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ABSTRACT
Objective: The objective of this study was to determine if there were any harmful effects of monosodium glutamate (MSG) on the liver of Wistar albino 
rats chronically at three different doses, namely, low, mid, and high doses equivalent to human consumption doses in developing countries.
Methods: The Wistar albino rats (n=24) were divided into four groups, namely control, Low dose MSG (180 mg/kg), Mid dose MSG (360 mg/kg), and 
High dose MSG (720 mg/kg). At the end of the experimental period (120 days), animal blood was collected retro-orbitally to analyze the liver enzymes 
such as aspartate transaminase (AST), alanine transaminase (ALT), alkaline phosphatase (ALP), Total protein, Albumin, and Total Bilirubin in blood 
serum. Lipid profiles, namely, Triglycerides, low-density lipoprotein (LDL), high-density lipoprotein (HDL), and Total cholesterol were subjected to 
analysis using blood serum.
Results: Significant increase (p<0.05) in AST, ALT, ALP, and total bilirubin in serum of MSG induced low, mid, and high dose groups when compared 
to control group were recorded. There was a significant increase (p<0.05) in LDL, decrease in HDL, increase in total cholesterol and triglycerides of 
MSG-induced animal groups.
Conclusion: The effects of MSG on serum liver enzymes and lipid profiles in this present animal study were not severely alarming even though the 
dosage was chronic which opens further discussion on the controversies revolving around MSG.
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INTRODUCTION
Monosodium glutamate (MSG) is one of the most commonly known 
and widely used food additives throughout the world, employed in 
a wide variety of food flavors. Seaweed was the first source of MSG 
in Japan in 1908 [1]. MSG is also commercially called as Ajinomoto 
(C5 H8 NO4 Na) which is the salt of L-glutamic acid and found naturally 
as free or bound glutamate in food proteins [2]. MSG imparts a 
special category of taste called as “Umami” or “Savory” or “Broth-
like” or “Meaty taste” which is revolutionizing the food industry at 
the cost of negative effects on health [3]. In industrialized countries, 
the average daily consumption of MSG is around 0.3–1 g/day which 
is 2 to 3 times more in developing Asian countries [4]. Asia is one of 
the largest producers of MSG and steady increase in its production, 
which indirectly reflects the elevated consumption of MSG in humans 
throughout the world [5]. Most of cuisines and packaged food 
industries around the world invariable adopt MSG as flavor-enhancing 
agent. There is a lot of controversy prevailing in scientific communities 
regarding the safety of MSG, even though FDA marked “MSG as safe for 
human consumption” [6]. The Liver is one of the primary organs of the 
human body involved in detoxification and metabolism. Earlier studies 
show that administration of MSG in animals causes hepatotoxicity by 
altering liver enzymes such as Alanine Aminotransferase, Aspartate 
Aminotransferase, γ-glutamyltransferase, and bilirubin in serum as 
well as causing oxidative stress in the liver by depleting endogenous 
antioxidants such as Catalase, Superoxide dismutase and reduced 
glutathione [7-10]. Even MSG is most commonly employed to induce 
obesity models in animal studies as it modifies the lipid profile in 
biological systems [11-13]. Earlier studies clearly show that MSG 
increases low-density lipoprotein (LDL) cholesterol, triglycerides, 
and decreases high-density lipoprotein (HDL) cholesterol [14,15]. The 
studies examining MSG have not been able to clearly determine MSG 
dosage that meets human consumption geographically and as a result, 
many studies lack clarity in the use of food-grade MSG with route 
of administration other than orally [16]. Therefore, we speculated 
chronic use of MSG at three different doses (low, mid, and high) in 
animals based on human consumption of MSG in developing countries 
may induce hepatotoxicity biochemically.
MATERIALS AND METHODS
Animals
Adult Wistar albino rats of either sex (n=24) were used for the study. 
Inbred rats were housed in our animal facilities at 23±1°C with a 12 h 
light and supplied with a temperature-adequate amount of drinkable 
tap water and standard laboratory chow. The rats were selected 
randomly for the study and acclimatized before initiating the study. 
Animal handling and procedural protocols were followed based 
on guidelines from the Committee for the Purpose of Control and 
Supervision of Experiments on Animals. Institutional Animal Ethical 
Committee (IAEC) had approved the study before initiation of the 
experiment with the Reg no: VIMS/IAEC/2016/03.
Experimental design
The chronic study was performed on healthy twenty-four adult Wistar 
albino rats. After acclimatization, the rats of either sex were assigned 
randomly to four groups (n=6 for each group). The Group I was 
used as control which was fed distilled water. The Group II received 
MSG of 180 mg/kg body weight (Low dose). The Group III received 
MSG of 360 mg/kg body weight (Mid dose). The Group IV received MSG 
of 720 mg/kg body weight (High dose). MSG was administered daily 
by oral gavage for 120 days. Following the 120-day experimental 
period, the rats were subjected to blood collection retro-orbitally for 
biochemical analysis.
© 2021 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons.org/
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Biochemical assays
The retro-orbital collection of blood in rats was performed after the 
completion of chronic period of animal dosing. The collected 2 ml of 
blood was centrifuged at 3000 RPM for 10 min and serum was collected 
for liver function test using an autoanalyzer. The collected serum was 
stored in a -80 degree Celsius cold storage facility. Then the serum was 
subjected to assay of liver enzymes such as alanine transaminase (ALT), 
aspartate transaminase (AST), alkaline phosphatase (ALP), albumin, 
total protein, and total bilirubin. For the Liver function test, commercial 
kits were used and analyzed using an autoanalyser. The lipid profile 
analysis consisting of LDL, HDL, total cholesterol, and triglycerides 
were also determined from serum using an autoanalyzer.
Statistical analysis
For statistical analysis, data were processed and analyzed using 
Graphpad Prism software 9.1.2. The data were explicited as 
mean±standard deviation (SD). The analysis was based on one-way 
ANOVA and followed by Tukey’s post-hoc test. Analyzed results were 
contemplated significant if p<0.05. The p-values in the current study 




The liver function test results show that there was a significant 
(p<0.05) difference between control and MSG-induced groups except 
for total protein and albumin (Table 1). The AST levels of MSG-induced 
groups were significantly (p<0.05) increased when compared to 
the control group. The MSG-induced groups exhibited significantly 
(p<0.05) increased Alanine Aminotransferase and ALP when compared 
to control group. The observation of significant (p<0.05) increase in 
total bilirubin was recorded in the MSG-induced group when compared 
to the control group. There is no conclusive difference statistically 
between MSG-induced groups and treatment groups for total protein 
and albumin.
Lipid profile test
Lipid profile parameters show significant differences (p<0.05) between 
control and MSG-induced groups. Triglyceride shows a significant 
(p<0.05) increase in MSG-induced groups when compared with the 
control group (Fig. 1). The level of HDL was significantly lower (p<0.05) 
in all monosodium-induced groups when compared with the control 
group (Fig. 2). All MSG -induced groups show an increase in LDL when 
compared to control groups (Fig. 3). The results of total cholesterol were 
significantly (p<0.05) increased in all MSG-induced groups compared to 
the control group (Fig. 4).
DISCUSSION
Earlier investigations similar to my findings showed that MSG causes 
liver damage interpreted using liver enzyme profile alterations. These 
investigations cannot be extrapolated to humans as those similar 
previous studies differed in the human equivalent dosage of MSG, route 
of administration and period of administration. The present study 
focused on the human equivalent dosage of MSG at low, mid and high 
dosage chronically based on average MSG consumption in developing 
Asian countries.
A study of liver function tests for groups induced by MSG shows that 
chronic administration of MSG damages liver cells. AST exhibiting 
16.28%, 34.57% and 42.08% increase in low, mid and high MSG 
induced group when compared to control animals concludes that 
hepatic cellular damage caused by MSG. The considerable increase 
in ALT and ALP in monosodium induced groups were more or less 
similar to AST levels which reinforces that hepatocellular leakage of 
those enzymes due to the liver injury caused by MSG [10]. The analysis 
of AST and ALT enzymes for groups induced with MSG (low, mid, and 
Table 1: Effect of MSG on serum liver enzymes
Parameters Group I (Control) Group II (Low dose) Group III (mid dose) Group IV (High dose)
AST (IU/L) 91.74±7 106.67±9.97** 123.45±5.47**** 130.33±3.92****
ALT (IU/L) 63.50±1.14 73.30±1.89* 76.69±6.84** 80.67±9.75***
ALP (IU/L) 11.72 ±0.48 13.46±1.24* 22.38±1.44**** 28.30±0.88****
Total Protein (g/dl) 8.39±0.52 8.72±0.78 10.01±1.83 9.26±0.65
Albumin (g/dl) 4.46 ±0.97 4.49±0.32 4.16±1.06 5.58±0.68
Total Bilirubin (mg/dl) 0.27±0.03 0.40±0.06** 0.41±0.04** 0.048±0.07****
Values are expressed as mean±SD. *Significantly different from the control group at p<0.05. **Significantly different from the control group at p<0.01. ***Significantly 
different from the control group at p<0.001. ****Significantly different from the control group at p<0.0001. ALT: Alanine transaminase, AST: Aspartate transaminase, 
ALP: Alkaline phosphatase, MSG: Monosodium glutamate
Fig. 2: Effect of Monosodium glutamate on serum High Density 
Lipoprotein (Values are expressed as mean±SD. *Significantly 
different from the control group at p<0.05. **Significantly 
different from the control group at p<0.01. ***Significantly 
different from the control group at p<0.001. ****Significantly 
different from the control group at p<0.0001)
Fig. 1: Effect of Monosodium glutamate on serum triglycerides 
(Values are expressed as mean±SD. *Significantly different 
from the control group at p<0.05. **Significantly different from 
the control group at p<0.01. ***Significantly different from the 
control group at p<0.001. ****Significantly different from the 
control group at p<0.0001)
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high doses) displays possible damage to liver cell membrane and 
cytosol due to monosodium induced oxidative stress which may would 
have triggered the hepatocytes to become leaky, releasing those liver 
enzymes in serum [7,17]. The current finidings were similar to previous 
studies pertaining to liver but not to the extent of severe damage. The 
total bilirubin altered elevation in monosodium induced groups when 
compared to control group may conclude dysfunctional liver cells failed 
to process bilirubin from the blood for bile production. The current 
study results show that hepatocellular damage at low dose MSG induced 
group is very minimal contrasting to mid and high dose MSG induced 
groups. These changes induced by MSG was less than 2 or 3 times in 
all MSG induced groups compared to control, which may indicate that 
liver damage was mild [18]. The reason for hepatic cell damage induced 
by MSG may be attributed to increased glutamate level in biological 
systems, which indeed stimulated Reactive Oxygen Species production 
either by Nicotinamide adenine dinucleotide reduction and ammonium 
formation [19]. Involvement of MSG in glutamine metabolism may also 
speculate increased glutamine altering redox status of cell by altered 
regulation of signalling systems in the living cell [20]. Insignificant 
differences in total protein and albumin may conclude that there was 
no alteration of total protein levels as the damage to the liver was mild. 
Leaving mild liver damage untreated, can lead to Non-Alcoholic Fatty 
Liver Disease, Non-Alcoholic Steatohepatitis, and liver cirrhosis if the 
drug toxicity persists for a prolonged period of time [14].
When compared to controls, MSG significantly increases LDL in rats, 
indicating that it negatively affects lipid metabolism [15]. Increased 
LDL may indicate the presence of atherosclerotic deposits on blood 
vessels when MSG was chronically consumed in rats [21]. MSG 
consumption inducing low HDL levels in affected groups may indicate 
the unhealthy fat deposits in peripheral tissues and the vascular 
system reinforcing the high LDL levels. In accordance with previous 
studies, high serum cholesterol level in monosodium-induced groups 
as well as the increase in triglycerides of high dose monosodium-
induced groups may predict the signs of cardiovascular diseases and 
hyperlipidemia [17]. The erratic lipid profiles in monosodium induced 
group may attribute to increased β oxidation of fatty acids, elevated 
3-hydroxyl-3- methylglutaryl coenzyme A reductase [22]. The crucial 
role of MSG affected liver may play a vital role in the faulty increase or 
decrease of lipid profile parameters of rat [23].
CONCLUSION
Using the current study findings, it is extrapolated that MSG may have 
toxic effects on chronic consumption in rats but not to the extent of 
adversity. MSG safety concerns have been debated in the scientific 
community regularly due to the lack of thorough research and the 
controversies around it. In addition, more studies should be conducted 
to determine whether the MSG is really harming the living system 
adversely when consumed chronically. The future research should focus 
on whether harmful effects of MSG may be repairable by the body’s own 
healing mechanisms or by natural food supplements that are part and 
parcel of today’s lifestyle.
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